Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06330714 · ClinicalTrials.gov registry record
Remote Monitoring of Chronic Illness Patients With a IHAP Home Wireless Hub and Vitals Measurements
A clinical trial of Chronic Disease of Cardiovascular System, sponsored by Aventyn.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT06330714: Completed study of Chronic Disease of Cardiovascular System, sponsored by Aventyn.
NCT06330714 is a study of Chronic Disease of Cardiovascular System that has completed, run by Aventyn. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06330714, a study of Chronic Disease of Cardiovascular System, has completed, sponsored by Aventyn.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is planned as a feasibility study. The primary objective is to evaluate a specially designed patient monitoring software Vitalbeat and standard mobile device hub termed Intel Health Application Platform (IHAP) in terms of its reliability, seamless data transmission and early data availability to the physician to improve patient physician interaction. The second objective is assessing patient response to use of mobile device monitoring and patient self-monitoring skills to transmit vital signs data using the IHAP wireless home hub device
Primary Outcome
he primary objective is to evaluate a specially designed patient monitoring software and standard mobile device hub in terms of its reliability, seamless data transmission and early data availability to the physician to improve patient physician interaction once per day for 30 days.
Conditions Studied
Interventions
- OTHER Symptoms of chronic illness.
Study Locations (1)
Arizona
- Institute for Liver Health - Chandler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2018-12-30 |
What the finished NCT06330714 record still lists
NCT06330714 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 1 condition, with Chronic Disease of Cardiovascular System appearing as the primary indexed condition, and to 1 intervention - of which Symptoms of chronic illness. is the first listed.
NCT06330714 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06330714 about?
NCT06330714 is a clinical study titled "Remote Monitoring of Chronic Illness Patients With a IHAP Home Wireless Hub and Vitals Measurements". This is planned as a feasibility study. The primary objective is to evaluate a specially designed patient monitoring software Vitalbeat and standard mobile device hub termed Intel Health Application Platform (IHAP) in terms of its reliability, seamless data transmission and early data availability ...
What is the current status of trial NCT06330714?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2018-07-01. Estimated completion is 2018-12-30.
What conditions does trial NCT06330714 study?
This clinical trial studies the following conditions: Chronic Disease of Cardiovascular System.
What interventions are being tested in trial NCT06330714?
The interventions under investigation include: Symptoms of chronic illness. (OTHER).
Who is sponsoring clinical trial NCT06330714?
This trial is sponsored by Aventyn, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06330714 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI